Fact CheckerSign in

NCT06064682Recruiting

An Organoid-based Functional Precision Medicine Trial in Osteosarcoma

An Organoid-based Functional Precision Medicine Trial in Osteosarcoma: PREMOST

Source: ClinicalTrials.gov · Last updated 11 May 2026

Brief summary (registry, in English)

The purpose of this study is to examine if we can predict sensitivity of osteosarcoma to different chemotherapy agents using tissue cultures in the laboratory. We know that different chemotherapy agents can be used in the treatment, but not every sarcoma responds to them equally. It is important to understand if testing of the tissue obtained during a routine biopsy or surgery may be useful in selecting appropriate treatments. In addition, additional testing of the tumor, including genetic testing, will help us to understand osteosarcoma better.

Status (registry)
Recruiting
Study type
Observational
Enrollment
40 (estimated)
First submitted
26 Sept 2023
Start date
Feb 2024
Primary completion date
Jan 2027
Lead sponsor
Jonsson Comprehensive Cancer Center
NCT number
NCT06064682

What you commit to

  • Study type: Observational
  • Planned participants: 40
  • From Feb 2024 to the primary completion date, Jan 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Inclusion / exclusion criteria - Group1:
  • \- Patients without diagnosis of osteosarcoma and whose imaging studies are suggestive of osteosarcoma and who are planned to undergo biopsy or surgery for diagnostic purposes
  • Inclusion / exclusion criteria - Group 2:
  • \- Patients whose imaging studies are suggestive of metastatic osteosarcoma and who are planned to undergo biopsy or surgery for diagnostic purposes

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UCLA / Jonsson Comprehensive Cancer Center
Coordinator of this site? Confirm its status
Los AngelesUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.